Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces today the demonstration of AI generated content with AI narration capabilities on its recently launched Version 6.0 platform, complementing its recent GPT-4 integration. The capabilities, demonstrated in Amesite’s free-to-the-public course on ChatGPT, demonstrate how content can be created with high efficiency and scalability, along with purpose-built, AI-driven features to support user learning.
ImmunoGen’s Flagship Cancer Therapy Draws AbbVie’s Attention With $10.1B Deal
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC) approved f